insights_auto
Hvorfor har ARGX gått ned? 4,09%?
Gå mer i dybdenchevron_right
ARGX:EBR
argenx SE
727,60 €
arrow_downward
−4,09%(−31,00) 1 D
16. okt., 17:39:35 GMT+2 · EUR
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for ARGX …
Åpne
759,20 €
Høy
761,80 €
Lav
727,60 €
Markedsverdi
48,36 mrd.
Snittvolum
86,90k
Volum
96,25k
P/E-forhold
30,95
52 u høy
925,00 €
52 u lav
568,40 €
EPS
23,51 €
Utestående aksjer
35,93 mill.
Antall ansatte
2k
Åpne
759,20 €
Høy
761,80 €
Lav
727,60 €
Markedsverdi
48,36 mrd.
Snittvolum
86,90k
Volum
96,25k
P/E-forhold
30,95
52 u høy
925,00 €
52 u lav
568,40 €
EPS
23,51 €
Utestående aksjer
35,93 mill.
Antall ansatte
2k
Nyhetssaker
Fra nettkilder og nyhetspartnere
ad-hoc-news.de
·
for 10 timer siden
argenx reports trial results: what it means for argenx stock
TipRanks
·
for 21 timer siden
Argenx Stock Stumbles As Trial Failure Haunts Rally
Yahoo Finance
·
for 1 døgn siden
Zacks Investment Ideas feature highlights: Cummins, Argenx and PACCAR
Simply Wall Street
·
for 3 døgn siden
Halozyme Stock Has The Bull Case Changed After Argenx Deal Expansion?
Profil
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
Om argenx SE